Christopher Liddle
14Patents
2h-index
13Co-inventors
51Inventor score
Filing activity: May 20, 1999 → Sep 1, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10077268B2 | FXR agonists and methods for making and using | Chemistry; Metallurgy | 7 | Active |
| US8318708B2 | Use of vitamin D receptor agonists, ligands, and precursors to treat pancreatic fibrosis | Physics | 4 | Active |
| US9872866B2 | Vitamin D receptor/SMAD genomic circuit gates fibrotic response | Physics | 2 | Active |
| US10301268B2 | Analogs of fexaramine and methods of making and using | Chemistry; Metallurgy | 2 | Active |
| US7531712B2 | P450 gene regulation | Human Necessities | 0 | Expired |
| US10238667B2 | Vitamin D receptor/SMAD genomic circuit gates fibrotic response | Physics | 0 | Active |
| US7638614B2 | Xenobiotic related induction of gene expression | Human Necessities | 0 | Expired |
| US8629318B2 | Transgenic animals for analyzing CYP3A4 cytochrome P450 gene regulation | Human Necessities | 0 | Active |
| US6984489B1 | Cytochrome P450 transcriptional enhancer nucleic acid molecule | Human Necessities | 0 | Expired |
| US10450277B2 | Analogs of fexaramine and methods of making and using | Chemistry; Metallurgy | 0 | Active |
| US9029336B2 | Xenobiotic related induction of gene expression | Human Necessities | 0 | Active |
| US10815203B2 | Analogs of fexaramine and methods of making and using | Chemistry; Metallurgy | 0 | Active |
| US8088968B2 | Transgenic animals for analyzing CYP3A4 cytochrome P450 gene regulation | Human Necessities | 0 | Active |
| US11440889B2 | Analogs of fexaramine and methods of making and using | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.